miRNA Sequencing And Assay Market Size, Share & Trends Report

miRNA Sequencing And Assay Market Size, Share & Trends Analysis Report By Product & Service, By Technology, By Workflow, By Application (Cancer, Autoimmune Disease, Schizophrenia), By End-use, By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Jul, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-4-68039-394-2
  • Format: Electronic (PDF)
  • Historical Data: 2017 - 2019
  • Number of Pages: 136

Table of Content

Chapter 1 Methodology and Scope
                   1.1 Research Scope
                       1.1.1 Estimates and Forecast Timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased Database
                       1.3.2 GVR’s Internal Database
                       1.3.3 Secondary Sources
                           1.3.3.1 List of secondary data sources
                       1.3.4 Primary Research
                   1.4 Information or Data Analysis
                       1.4.1 Data Analysis Models
                   1.5 Market Formulation & Validation
                       1.5.1 Region-wise market: Base estimates
                   1.6 Objectives
                       1.6.1 Objective 1:
                       1.6.2 Objective 2:
Chapter 2 Executive Summary
                   2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
                   3.1 Industry Pyramid Analysis
                       3.1.1 Parent & ANCILLARY Market Analysis
                   3.2 Market Segmentation & Scope
                   3.3 Market Dynamics
                       3.3.1 Market driver analysis
                           3.3.1.1 Advantages of miRNA Sequencing
                           3.3.1.2 MiRNAs as critical regulators of health and disease
                           3.3.1.3 Rise in prevalence of cancer and autoimmune disorders
                           3.3.1.4 Rise in adoption of RNA sequencing protocols in biotechnology research
                       3.3.2 Market restraint analysis
                           3.3.2.1 Limitations associated with Bioinformatic Analysis of MicroRNA Sequencing Data
                       3.3.3 Market opportunity analysis
                           3.3.3.1 Efforts taken to optimize miRNA-seq data processing
                       3.3.4 Market challenge analysis
                           3.3.4.1 Challenges associated with the validation and prediction of miRNA targetome
                   3.4 Penetration & Growth Prospect Mapping for Technology, 2020
                   3.5 COVID-19 Impact Analysis on Market
                   3.6 BUSINESS ENVIRONMENT ANALYSIS
                       3.6.1 MiRNA sequencing and assay Market - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
                       3.6.2 Porter’s Five Forces Analysis
                   3.7 Major Deals & Strategic Alliances Analysis
                       3.7.1 Product developments
                       3.7.2 Merger & acquisition
                       3.7.3 Agreement
                       3.7.4 Collaboration & partnership
Chapter 4 Product & Service Business Analysis
                   4.1 miRNA sequencing and assay market: Product & Services Movement Analysis, 2020 & 2028
                   4.2 Products
                       4.2.1 MiRNA Sequencing and Assay Products Market, 2017 - 2028 (USD Million)
                       4.2.2 Library Preparation Kits
                           4.2.2.1 Library Preparation Kits market, 2017 - 2028 (USD Million)
                       4.2.3 Sequencing Consumables
                           4.2.3.1 Sequencing Consumables market, 2017 - 2028 (USD Million)
                       4.2.4 Instruments
                           4.2.4.1 Instruments market, 2017 - 2028 (USD Million)
                   4.3 Services
                       4.3.1 MiRNA Sequencing and Assay Services Market, 2017 - 2028 (USD Million)
Chapter 5 Technology Business Analysis
                   5.1 miRNA sequencing and assay market: Technology Movement Analysis, 2020 & 2028
                   5.2 Sequencing by Synthesis
                       5.2.1 Sequencing By Synthesis Market, 2017 - 2028 (USD Million)
                   5.3 Sequencing by Oligonucleotide Ligation and Detection (SOLiD)
                       5.3.1 Sequencing By Oligonucleotide Ligation and Detection (SOLiD) Market, 2017 - 2028 (USD Million)
                   5.4 Nanopore Sequencing
                       5.4.1 Nanopore Sequencing Market, 2017 - 2028 (USD Million)
                   5.5 Sanger Sequencing
                       5.5.1 Sanger Sequencing Market, 2017 - 2028 (USD Million)
                   5.6 Single Molecule Real-time (SMRT) Sequencing
                       5.6.1 Single Molecule Real-time (SMRT) Sequencing Market, 2017 - 2028 (USD Million)
Chapter 6 Workflow Business Analysis
                   6.1 miRNA Sequencing and Assay Market: Workflow Movement Analysis, 2020 & 2028
                   6.2 Library Preparation
                       6.2.1 Library Preparation Workflow Market, 2017 - 2028 (USD Million)
                   6.3 Sequencing
                       6.3.1 Sequencing Workflow Market, 2017 - 2028 (USD Million)
                   6.4 Data Analysis & Storage
                       6.4.1 Data Analysis & Storage Workflow Market, 2017 - 2028 (USD Million)
Chapter 7 Application Business Analysis
                   7.1 miRNA Sequencing And Assay Market: Applications Movement Analysis, 2020 & 2028
                   7.2 Cancer
                       7.2.1 Cancer Market, 2017 - 2028 (USD Million)
                   7.3 Polyglutamine Diseases
                       7.3.1 Polyglutamine Diseases Market, 2017 - 2028 (USD Million)
                   7.4 Autoimmune Disease
                       7.4.1 Autoimmune Disease Market, 2017 - 2028 (USD Million)
                   7.5 Schizophrenia
                       7.5.1 Schizophrenia Market, 2017 - 2028 (USD Million)
                   7.6 Others
                       7.6.1 Others Market, 2017 - 2028 (USD Million)
Chapter 8 End-use Business Analysis
                   8.1 miRNA Sequencing And Assay Market: End-use Movement Analysis, 2020 & 2028
                   8.2 Pharmaceutical & Biotechnology Industry
                       8.2.1 Pharmaceutical & Biotechnology Industry Market, 2017 - 2028 (USD Million)
                   8.3 Research and Academic Institutes
                       8.3.1 Research and Academic Institutes Market, 2017 - 2028 (USD Million)
                   8.4 Contract Research Organizations
                       8.4.1 Contract Research Organizations Market, 2017 - 2028 (USD Million)
Chapter 9 Regional Business Analysis
                   9.1 MiRNA Sequencing & Assay Market Share By Region, 2020 & 2028
                   9.2 North America
                       9.2.1 North America MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
                       9.2.2 U.S.
                           9.2.2.1 U.S. miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.2.2.2 U.S. miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.2.2.3 U.S. miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.2.2.4 U.S. miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.2.2.5 U.S. miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                       9.2.3 Canada
                           9.2.3.1 Canada miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.2.3.2 Canada miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.2.3.3 Canada miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.2.3.4 Canada miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.2.3.5 Canada miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                   9.3 Europe
                       9.3.1 Europe MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
                       9.3.2 U.K.
                           9.3.2.1 U.K. miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.3.2.2 U.K. miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.3.2.3 U.K. miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.3.2.4 U.K. miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.3.2.5 U.K. miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                       9.3.3 Germany
                           9.3.3.1 Germany miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.3.3.2 Germany miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.3.3.3 Germany miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.3.3.4 Germany miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.3.3.5 Germany miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                       9.3.4 France
                           9.3.4.1 France miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.3.4.2 France miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.3.4.3 France miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.3.4.4 France miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.3.4.5 France miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                       9.3.5 Italy
                           9.3.5.1 Italy miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.3.5.2 Italy miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.3.5.3 Italy miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.3.5.4 Italy miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.3.5.5 Italy miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                       9.3.6 Spain
                           9.3.6.1 Spain miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.3.6.2 Spain miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.3.6.3 Spain miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.3.6.4 Spain miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.3.6.5 Spain miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                   9.4 Asia Pacific
                       9.4.1 Asia Pacific MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
                       9.4.2 China
                           9.4.2.1 China miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.4.2.2 China miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.4.2.3 China miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.4.2.4 China miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.4.2.5 China miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                       9.4.3 Japan
                           9.4.3.1 Japan miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.4.3.2 Japan miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.4.3.3 Japan miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.4.3.4 Japan miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.4.3.5 Japan miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                       9.4.4 India
                           9.4.4.1 India miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.4.4.2 India miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.4.4.3 India miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.4.4.4 India miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.4.4.5 India miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                       9.4.5 Australia
                           9.4.5.1 Australia miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.4.5.2 Australia miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.4.5.3 Australia miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.4.5.4 Australia miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.4.5.5 Australia miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                       9.4.6 South Korea
                           9.4.6.1 South Korea miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.4.6.2 South Korea miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.4.6.3 South Korea miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.4.6.4 South Korea miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.4.6.5 South Korea miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                   9.5 Latin America
                       9.5.1 Latin America MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
                       9.5.2 Brazil
                           9.5.2.1 Brazil miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.5.2.2 Brazil miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.5.2.3 Brazil miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.5.2.4 Brazil miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.5.2.5 Brazil miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                       9.5.3 Mexico
                           9.5.3.1 Mexico miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.5.3.2 Mexico miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.5.3.3 Mexico miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.5.3.4 Mexico miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.5.3.5 Mexico miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                   9.6 MEA
                       9.6.1 MEA MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
                       9.6.2 South Africa
                           9.6.2.1 South Africa miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.6.2.2 South Africa miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.6.2.3 South Africa miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.6.2.4 South Africa miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.6.2.5 South Africa miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
                       9.6.3 Saudi Arabia
                           9.6.3.1 Saudi Arabia miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
                           9.6.3.2 Saudi Arabia miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
                           9.6.3.3 Saudi Arabia miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
                           9.6.3.4 Saudi Arabia miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
                           9.6.3.5 Saudi Arabia miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Chapter 10 COMPETITIVE LANDSCAPE
                   10.1 Company categorization
                   10.2 Strategy framework
                       10.2.1 Thermo Fisher Scientific, Inc.
                           10.2.1.1 Company overview
                           10.2.1.2 Financial performance
                           10.2.1.3 Product benchmarking
                           10.2.1.4 Strategic initiatives
                       10.2.2 Illumina, Inc.
                           10.2.2.1 Company overview
                           10.2.2.2 Financial Performance
                           10.2.2.3 Product benchmarking
                       10.2.3 QIAGEN
                           10.2.3.1 Company overview
                           10.2.3.2 Financial Performance
                           10.2.3.3 Product benchmarking
                       10.2.4 PerkinElmer, Inc.
                           10.2.4.1 Company overview
                           10.2.4.2 Financial Performance
                           10.2.4.3 Product benchmarking
                       10.2.5 Abcam plc
                           10.2.5.1 Company overview
                           10.2.5.2 Financial Performance
                           10.2.5.3 Product benchmarking
                       10.2.6 New England Biolabs
                           10.2.6.1 Company overview
                           10.2.6.2 Financial Performance
                           10.2.6.3 Product benchmarking
                       10.2.7 Takara Bio Inc.
                           10.2.7.1 Company overview
                           10.2.7.2 Financial Performance
                           10.2.7.3 Product benchmarking
                           10.2.7.4 Strategic initiatives
                       10.2.8 Lexogen GmbH
                           10.2.8.1 Company overview
                           10.2.8.2 Financial Performance
                           10.2.8.3 Product benchmarking
                           10.2.8.4 Strategic initiatives
                       10.2.9 Norgen Biotek Corp.
                           10.2.9.1 Company overview
                           10.2.9.2 Financial Performance
                           10.2.9.3 Product benchmarking
                           10.2.9.4 Strategic initiatives
                       10.2.10 Maravai LifeSciences
                           10.2.10.1 Company overview
                               10.2.10.1.1 TriLink BioTechnologies
                           10.2.10.2 Financial Performance
                           10.2.10.3 Product benchmarking
                           10.2.10.4 Strategic initiatives
                       10.2.11 HTG Molecular Diagnostics, Inc.
                           10.2.11.1 Company overview
                           10.2.11.2 Financial performance
                           10.2.11.3 Product benchmarking
                           10.2.11.4 Strategic initiatives
                       10.2.12 Meridian Bioscience, Inc.
                           10.2.12.1 Company overview
                           10.2.12.2 Financial performance
                           10.2.12.3 Product benchmarking
                           10.2.12.4 Strategic initiatives
                       10.2.13 System Biosciences, LLC.
                           10.2.13.1 Company overview
                           10.2.13.2 Financial Performance
                           10.2.13.3 Product benchmarking


List of Tables

Table 1 Oxford Nanopore Technologies Product Comparison
Table 2 Comparison of Sanger Sequencing and NGS
Table 3 Illumina, Inc. Data Analysis & Storage Informatics Products offering
Table 4 MicroRNAs in Autoimmune Diseases
Table 5 U.S. miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 6 U.S. miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 7 U.S. miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 8 U.S. miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 9 U.S. miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 10 U.S. miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 11 Canada miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 12 Canada miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 13 Canada miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 14 Canada miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 15 Canada miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 16 Canada miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 17 U.K. miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 18 U.K. miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 19 U.K. miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 20 U.K. miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 21 U.K. miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 22 U.K. miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 23 Germany miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 24 Germany miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 25 Germany miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 26 Germany miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 27 Germany miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 28 Germany miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 29 France miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 30 France miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 31 France miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 32 France miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 33 France miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 34 France miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 35 Italy miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 36 Italy miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 37 Italy miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 38 Italy miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 39 Italy miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 40 Italy miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 41 Spain miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 42 Spain miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 43 Spain miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 44 Spain miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 45 Spain miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 46 Spain miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 48 China miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 49 China miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 50 China miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 51 China miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 52 China miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 53 China miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 54 Japan miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 55 Japan miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 56 Japan miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 57 Japan miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 58 Japan miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 59 Japan miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 60 India miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 61 India miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 62 India miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 63 India miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 64 India miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 65 India miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 66 Australia miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 67 Australia miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 68 Australia miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 69 Australia miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 70 Australia miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 71 Australia miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 72 South Korea miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 73 South Korea miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 74 South Korea miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 75 South Korea miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 76 South Korea miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 77 South Korea miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 78 Brazil miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 79 Brazil miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 80 Brazil miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 81 Brazil miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 82 Brazil miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 83 Brazil miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 84 Mexico miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 85 Mexico miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 86 Mexico miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 87 Mexico miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 88 Mexico miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 89 Mexico miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 91 South Africa miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 92 South Africa miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 93 South Africa miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 94 South Africa miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 95 South Africa miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 96 South Africa miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)
Table 97 Saudi Arabia miRNA sequencing and assay market, by product & service, 2017 - 2028 (USD Million)
Table 98 Saudi Arabia miRNA sequencing and assay market, by product, 2017 - 2028 (USD Million)
Table 99 Saudi Arabia miRNA sequencing and assay market, by technology, 2017 - 2028 (USD Million)
Table 100 Saudi Arabia miRNA sequencing and assay market, by workflow, 2017 - 2028 (USD Million)
Table 101 Saudi Arabia miRNA sequencing and assay market, by application, 2017 - 2028 (USD Million)
Table 102 Saudi Arabia miRNA sequencing and assay market, by end use, 2017 - 2028 (USD Million)


List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot, 2020, (USD Million)
Fig. 9 Generations of sequencing
Fig. 10 Market segmentation & scope
Fig. 11 Market trends & outlook
Fig. 12 Market driver relevance analysis (Current & future impact)
Fig. 13 Advantages of miRNA sequencing
Fig. 14 Market restraint analysis
Fig. 15 Market opportunity analysis
Fig. 16 Market challenge analysis
Fig. 17 Penetration & growth prospect mapping for technology, 2020
Fig. 18 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 19 Porter’s Five Forces Analysis
Fig. 20 miRNA sequencing and assay market: Product & Services outlook key takeaways
Fig. 21 miRNA sequencing and assay market: Product & Services movement analysis
Fig. 22 MiRNA Sequencing and Assay Products Market, 2017 - 2028 (USD Million)
Fig. 23 Library Preparation Kits Market, 2017 - 2028 (USD Million)
Fig. 24 Sequencing Consumables Market, 2017 - 2028 (USD Million)
Fig. 25 Instruments market, 2017 - 2028 (USD Million)
Fig. 26 MiRNA Sequencing and Assay Services Market, 2017 - 2028 (USD Million)
Fig. 27 miRNA sequencing and assay market: Technology outlook key takeaways
Fig. 28 miRNA sequencing and assay market: Technology movement analysis
Fig. 29 Thermo Fisher Scientific - Small RNA sequencing workflow for Ion Torrent next-generation sequencing systems
Fig. 30 Sequencing by Synthesis Market, 2017 - 2028 (USD Million)
Fig. 31 Sequencing by Oligonucleotide Ligation and Detection (SOLiD) Market, 2017 - 2028 (USD Million)
Fig. 32 Nanopore Sequencing Market, 2017 - 2028 (USD Million)
Fig. 33 Sanger Sequencing Market, 2017 - 2028 (USD Million)
Fig. 34 Single Molecule Real-time (SMRT) Sequencing Market, 2017 - 2028 (USD Million)
Fig. 35 miRNA sequencing and assay market: Workflow outlook key takeaways
Fig. 36 miRNA sequencing and assay market: Workflow movement analysis
Fig. 37 Library preparation workflow market, 2017 - 2028 (USD Million)
Fig. 38 Sequencing Workflow Market, 2017 - 2028 (USD Million)
Fig. 39 Data Analysis & Storage Workflow Market, 2017 - 2028 (USD Million)
Fig. 40 miRNA sequencing and assay market: Applications outlook key takeaways
Fig. 41 miRNA sequencing and assay market: Applications movement analysis
Fig. 42 Cancer Market, 2017 - 2028 (USD Million)
Fig. 43 Polyglutamine Diseases Market, 2017 - 2028 (USD Million)
Fig. 44 Autoimmune Disease Market, 2017 - 2028 (USD Million)
Fig. 45 Schizophrenia Market, 2017 - 2028 (USD Million)
Fig. 46 Others Market, 2017 - 2028 (USD Million)
Fig. 47 miRNA sequencing and assay market: End-use outlook key takeaways
Fig. 48 miRNA sequencing and assay market: End-use movement analysis
Fig. 49 Pharmaceutical & Biotechnology Industry Market, 2017 - 2028 (USD Million)
Fig. 50 Research and Academic Institutes Market, 2017 - 2028 (USD Million)
Fig. 51 Contract Research Organizations Market, 2017 - 2028 (USD Million)
Fig. 52 Regional marketplace: Key takeaway
Fig. 53 MiRNA sequencing & assay market: Regional movement analysis
Fig. 54 North America
Fig. 55 North America MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 56 U.S.
Fig. 57 Canada
Fig. 58 Europe
Fig. 59 Europe MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 60 U.K.
Fig. 61 Germany
Fig. 62 France
Fig. 63 Italy
Fig. 64 Spain
Fig. 65 Asia Pacific
Fig. 66 Asia Pacific MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 67 China
Fig. 68 Japan
Fig. 69 India
Fig. 70 Australia
Fig. 71 South Korea
Fig. 72 Latin America
Fig. 73 Latin America MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 74 Brazil
Fig. 75 Mexico
Fig. 76 MEA
Fig. 77 MEA MiRNA sequencing & assay market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 78 South Africa
Fig. 79 Saudi Arabia
Fig. 80 Company categorization
Fig. 81 Strategy framework

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.